PFS
BIIB icon

Penseco Financial Services’s Biogen BIIB Stock Holding History

Penseco Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$14K Buy
60
+10
+20% +$2.24K 0.01% 203
2013
Q2 		$11K Buy
+50
New +$10.7K 0.01% 196

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Penseco Financial Services's BIIB Position: Q3 2013 in Review

Penseco Financial Services increased its Biogen (BIIB) stake by 20% in Q3 2013, buying an estimated $2.24K and bringing the position to 60 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #203.

Penseco Financial Services first reported a position in BIIB in Q2 2013 and has held it in 2 quarters since. 656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

  • Penseco Financial Services held 60 shares of Biogen worth $14K as of Q3 2013.
  • Penseco Financial Services bought 10 Biogen shares in Q3 2013, an estimated $2.24K.
  • Biogen made up 0.01% of Penseco Financial Services's portfolio in Q3 2013, its #203 holding.
  • Penseco Financial Services first reported a position in Biogen in Q2 2013 and has held it in 2 quarters since.
  • 656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Penseco Financial Services's 13F filing for Q3 2013, filed 4 Oct 2013.